High-throughput functional mutagenesis studies for the analysis of BRCA1 gene variants

The program is developed within the Health Operating Plan, Trajectory 3, GENOMED Project, Objective 3, to create a pharmacogenomic model study system for the response to any possible variant of the BRCA1 gene